LoginSignup
Dexcom logo

Dexcom Stock

StockStock
ISIN: US2521311074
Ticker: DXCM
US2521311074
DXCM

Price

Frequently asked questions

What is Dexcom's market capitalization?

The market capitalization of Dexcom is $27.46B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is Dexcom's Price-to-Earnings (P/E) ratio?

The Price-to-Earnings (P/E) ratio (TTM) for Dexcom is 42.92. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.

What is the Earnings Per Share (EPS) for Dexcom?

Dexcom's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $1.638. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Dexcom's stock?

Currently, 24 analysts cover Dexcom's stock, with a consensus target price of $152.65. Analyst ratings provide insights into the stock's expected performance.

What is Dexcom's revenue over the trailing twelve months?

Over the trailing twelve months, Dexcom reported a revenue of $3.95B.

What is the EBITDA for Dexcom?

Dexcom's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $857.70M. EBITDA measures the company's overall financial performance.

What is the free cash flow of Dexcom?

Dexcom has a free cash flow of $535.00M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

What is the 5-year beta of Dexcom's stock?

The 5-year beta for Dexcom is 1.10. A beta value indicates the stock's volatility relative to the market; a beta greater than 1 means higher volatility.

How many employees does Dexcom have, and what sector and industry does it belong to?

Dexcom employs approximately 9,600 people. It operates in the Health Care sector, specifically within the Medical Equipment & Supplies industry.

What is the free float of Dexcom's shares?

The free float of Dexcom is 389.35M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap

 $27.46B

5Y beta

 1.10

EPS (TTM)

 $1.638

Free Float

 389.35M

P/E ratio (TTM)

 42.92

Revenue (TTM)

 $3.95B

EBITDA (TTM)

 $857.70M

Free Cashflow (TTM)

 $535.00M

Pricing

1D span
$69.33$75.37
52W span
$62.34$142.00

Analyst Ratings

The price target is $152.65 and the stock is covered by 24 analysts.

Buy

20

Hold

4

Sell

0

Information

DexCom, Inc. is a medical device company. The Company enables people to take real-time control of health through continuous glucose monitoring (CGM) systems. The Company is engaged in diabetes care technology. Based on the needs of users, caregivers, and providers, the Company works to simplify and improve diabetes management around the world. The Company is primarily focused on the design, development, and commercialization of CGM, systems for the management of diabetes by patients, caregivers, and clinicians around the world. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. Dexcom G6 is its integrated continuous glucose monitoring system (iCGM). Dexcom Stelo is designed specifically for people with type II diabetes who do not use insulin and are not at risk for hypoglycemia. The Dexcom Share remote monitoring system, offered for use with any Dexcom system, uses an app on the patient’s compatible mobile device.

9,600

Medical Equipment & Supplies

Health Care

Identifier

ISIN

US2521311074

Primary Ticker

DXCM

Knockouts

Join the conversation
Sign upLogin